Fundamental Expertise
Biopharmaceuticals
Biologics are the fastest growing segment of the pharmaceutical market displaying fierce competition among its players. The coming rise of biosimilars and the development of immunotherapies, new antibody variants as well as cell & gene therapies are constantly affecting the market.
Immuno-oncology
Immunotherapies are the next generation in the fight against cancer, showing considerable effectiveness and lesser toxicity as compared to traditional therapy.
Treatment strategies have expanded from targeted approaches to T-cell therapies and immune checkpoint inhibitors.
Gene Therapy
The last decades have been shaped by the rise of genetics.Terms like personalized medicine and genomic profiling are today's headliners. Gene therapies are aimed at the root of a disease instead of pure symptom treatment. Experts are forecasting a skyrocket take-off of gene therapeutics in the near future.
Further Life Science Industry Expertise
Life science is a broadening field with multiple applications. Biovisory's strategic support extends to the full spectrum of life science industries comprising Pharma, Medtech, Diagnostics, CDMO, API manufacturers and investors (PE/VC). Take a look at past projects and understand Biovisory's wide spectrum of knowledge.
